IPAR.NASDAQInterparfums INC

Form 4: Interparfums Officer Exercises Stock Options

Sentiment:

Insider Trading Report

📋All filings for Interparfums INC
🔒Login to Follow

Herve Bouillonnec, Global Chief Commercial Officer and Director of Interparfums Inc., exercised options to acquire 1,500 shares of common stock.

Summary

  • Herve Bouillonnec, Global Chief Commercial Officer and Director of Interparfums Inc. (IPAR), acquired 1,500 shares of common stock.
  • The transaction occurred on December 15, 2025, through the exercise of options at a price of $73.09 per share.
  • Following this transaction, Mr. Bouillonnec directly owns 1,500 shares of common stock.
  • He continues to hold various tranches of unexercised stock options with exercise prices ranging from $97.84 to $147.71 and $130.6, with expiration dates extending to December 30, 2030.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a routine transaction, an executive increasing their direct ownership stake can be seen as a positive signal of confidence in the company's future, assuming the exercise price is below the current market price.

Positives

  • The exercise of options by a key executive demonstrates continued alignment of management's interests with shareholders, as they increase their direct equity stake in the company.

Negatives

  • No direct negatives are indicated by this routine insider transaction.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction filing and does not provide specific insights into broader industry trends or competitive landscape for the fragrance and cosmetics industry.

Stakeholder Impact

  • Shareholders: The transaction indicates an executive's increased direct ownership, potentially aligning their interests more closely with long-term shareholder value. It does not directly impact the company's operational or financial performance.

Key Dates

DateDescription
12/31/2020Earliest exercisable date for a tranche of options with a $73.09 strike price.
12/31/2021Exercisable date for a tranche of options with a $73.09 strike price.
12/31/2022Exercisable date for a tranche of options with a $73.09 strike price.
12/31/2023Exercisable date for a tranche of options with a $73.09 strike price and for options with a $97.84 strike price.
12/29/2024Earliest exercisable date for a tranche of options with a $147.71 strike price.
12/31/2024Exercisable date for a tranche of options with a $73.09 strike price and for options with a $97.84 strike price.
12/15/2025Date of transaction where 1,500 shares were acquired through option exercise.
12/17/2025Signature date of the reporting person.
12/29/2025Earliest exercisable date for a tranche of options with a $147.71 strike price.
12/30/2025Expiration date for options with a $73.09 strike price.
12/31/2025Exercisable date for options with a $97.84 strike price and for options with a $130.6 strike price.
12/29/2026Earliest exercisable date for a tranche of options with a $147.71 strike price.
12/31/2026Exercisable date for options with a $97.84 strike price and for options with a $130.6 strike price.
12/29/2027Earliest exercisable date for a tranche of options with a $147.71 strike price.
12/31/2027Exercisable date for options with a $97.84 strike price and for options with a $130.6 strike price.
12/28/2028Expiration date for options with a $97.84 strike price and for options with a $147.71 strike price.
12/29/2028Earliest exercisable date for a tranche of options with a $147.71 strike price.
12/31/2028Exercisable date for options with a $97.84 strike price and for options with a $130.6 strike price.
12/28/2029Expiration date for options with a $147.71 strike price.
12/31/2029Exercisable date for options with a $130.6 strike price.
12/30/2030Expiration date for options with a $130.6 strike price.

Recommendation

hold

This Form 4 filing reports a routine insider transaction (option exercise) and does not contain information that would fundamentally alter the investment thesis for Interparfums Inc. It is a standard disclosure and typically does not warrant a change in investment recommendation. The executive's increased direct ownership is a minor positive, but not significant enough to change a 'hold' stance based solely on this filing.

Keywords

Interparfums, IPAR, Herve Bouillonnec, Insider Transaction, Stock Options, Common Stock, SEC Form 4, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.